CLVS - Clovis Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts10101212
Avg. Estimate-1.82-1.84-7.45-5.74
Low Estimate-2.38-2.5-8.79-7.32
High Estimate-1.54-1.46-6.7-4.81
Year Ago EPS-1.71-1.88-7.07-7.45
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts991211
Avg. Estimate36.42M39.18M141.26M208.18M
Low Estimate34.3M36.75M137.2M164.46M
High Estimate39M43M148M274.69M
Year Ago Sales22.76M30.35M95.39M141.26M
Sales Growth (year/est)60.00%29.10%48.10%47.40%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.6-1.72-1.74-1.71
EPS Actual-1.71-1.88-1.63-2.27
Difference-0.11-0.160.11-0.56
Surprise %-6.90%-9.30%6.30%-32.70%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.82-1.84-7.45-5.74
7 Days Ago-1.84-1.87-7.47-5.8
30 Days Ago-1.73-1.74-6.82-5.19
60 Days Ago-1.72-1.73-6.8-5.17
90 Days Ago-1.72-1.72-6.84-5.38
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1311
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLVSIndustrySectorS&P 500
Current Qtr.-6.40%N/AN/A-0.00
Next Qtr.2.10%N/AN/A0.08
Current Year-5.40%N/AN/A0.03
Next Year23.00%N/AN/A0.10
Next 5 Years (per annum)33.70%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A